These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23308059)

  • 1. Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.
    Rehemtulla A
    Neoplasia; 2012 Dec; 14(12):1278-89. PubMed ID: 23308059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor Heterogeneity in Breast Cancer.
    Beca F; Polyak K
    Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance.
    Marusyk A; Janiszewska M; Polyak K
    Cancer Cell; 2020 Apr; 37(4):471-484. PubMed ID: 32289271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy.
    Stakheyeva M; Riabov V; Mitrofanova I; Litviakov N; Choynzonov E; Cherdyntseva N; Kzhyshkowska J
    Curr Pharm Des; 2017; 23(32):4807-4826. PubMed ID: 28714406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
    Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
    OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass Spectrometry Imaging for the Investigation of Intratumor Heterogeneity.
    Balluff B; Hanselmann M; Heeren RM
    Adv Cancer Res; 2017; 134():201-230. PubMed ID: 28110651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.
    Gonzalez de Castro D; Clarke PA; Al-Lazikani B; Workman P
    Clin Pharmacol Ther; 2013 Mar; 93(3):252-9. PubMed ID: 23361103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
    Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
    Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular heterogeneity and molecular evolution in cancer.
    Almendro V; Marusyk A; Polyak K
    Annu Rev Pathol; 2013 Jan; 8():277-302. PubMed ID: 23092187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary scalpels for dissecting tumor ecosystems.
    Rosenbloom DIS; Camara PG; Chu T; Rabadan R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):69-83. PubMed ID: 27923679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumor heterogeneity: seeing the wood for the trees.
    Yap TA; Gerlinger M; Futreal PA; Pusztai L; Swanton C
    Sci Transl Med; 2012 Mar; 4(127):127ps10. PubMed ID: 22461637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance.
    Ilan Y; Spigelman Z
    Cancer Treat Res Commun; 2020; 25():100240. PubMed ID: 33246316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations.
    Guernet A; Mungamuri SK; Cartier D; Sachidanandam R; Jayaprakash A; Adriouch S; Vezain M; Charbonnier F; Rohkin G; Coutant S; Yao S; Ainani H; Alexandre D; Tournier I; Boyer O; Aaronson SA; Anouar Y; Grumolato L
    Mol Cell; 2016 Aug; 63(3):526-38. PubMed ID: 27453044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.
    Lim ZF; Ma PC
    J Hematol Oncol; 2019 Dec; 12(1):134. PubMed ID: 31815659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
    Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
    Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
    Mroz EA; Rocco JW
    Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma.
    Rasmussen JH; Olin AB; Lelkaitis G; Hansen AE; Andersen FL; Johannesen HH; Kjaer A; Fischer BM; Specht L; Bentzen SM; von Buchwald C; Wessel I; Vogelius IR
    Eur J Radiol; 2021 Jun; 139():109668. PubMed ID: 33848777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.